LegoChem Biosciences Inc Capital Reinvestment Ratio

Latest as of December 2024: 0.07x

LegoChem Biosciences Inc capital reinvestment ratio. LegoChem Biosciences Inc (141080) has a Capital Reinvestment Ratio of 0.07x as of December 2024, meaning it reinvests 0% of its operating cash flow (₩78.48 Billion) in capital expenditures (₩5.70 Billion). Check total reinvestment intensity of LegoChem Biosciences Inc to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

₩78.48 Billion

KRW

Capital Expenditures

₩5.70 Billion

KRW

Data as of

Dec 2024

Most recent filing

Capital Reinvestment Ratio of LegoChem Biosciences Inc (2019–2024)

Capital reinvestment ratio of LegoChem Biosciences Inc from 2019 to 2024. This chart tracks LegoChem Biosciences Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore LegoChem Biosciences Inc equity growth rate to track the company's year-over-year net asset growth rate.

LegoChem Biosciences Inc Capital Reinvestment Ratio by Year (2019–2024)

LegoChem Biosciences Inc capital reinvestment ratio by year from 2019 to 2024. For the full cash flow conversion analysis, see 141080 cash flow metrics.

Year	Reinvestment Ratio	Operating CF (KRW)	Capital Expenditures	YoY Change
2024	0.07x	₩78.48 Billion	₩5.70 Billion	▼ -48.0%
2019	0.14x	₩24.11 Billion	₩3.37 Billion	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow